To assess the impacts of GSG2 knockdown on thyroid cancer cell functions, we utilized two RNA interference plasmids, namely shGSG2-1 and shGSG2-2, both designed to target GSG2. The gene discussed is HASPIN; the disease is thyroid cancer.